Olinvacimab (Anti-VEGFR2 / KDR / CD309)
Olinvacimab (Anti-VEGFR2 / KDR / CD309) is a fully human monoclonal antibody targeting VEGFR2. It has antiangiogenic activity and can be used for the research of recurrent glioblastoma and breast cancer. MW :146.88 KD
Supplier | Selleck Chemicals |
---|---|
Product # | A2979 |
Sku # | A2979-1mg |
Pricing | 1mg, $470.00 |